未登录

N

Na Wu

Fujian Medical University

H指数:20

被引数:1,230

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Synergistic Coupling of a Spherical Nucleic Acid DNA Walker and a Redox Cascade for Self-Calibrated Ratiometric Detection of Endocrine Disruptors

Biosensors and Bioelectronics

IF10.5

2026-01-160

PRE

Author Correction: Molecular mechanisms of MAZ targeting up-regulation of NDUFS3 expression to promote malignant progression in melanoma

作者更正：MAZ靶向上调NDUFS3表达以促进黑色素瘤恶性进展的分子机制

Communications Biology

IF5.1

2025-08-230

OAAI

NALCN expression is down-regulated and associated with immune infiltration in gastric cancer

FRONTIERS IN IMMUNOLOGY

IF5.9

2025-02-120

OAAI

Enhanced butanol production through intracellular NADH regeneration in CdSe-C. acetobutylicumg semi-photosynthetic biohybrid system

BIORESOURCE TECHNOLOGY

IF9

2025-02-010

PRE

Creating a System of Dual Regulation of Translation and Transcription to Enhance the Production of Recombinant Protein

BIOTECHNOLOGY JOURNAL

IF3.1

2024-12-160

PRE

NOD2 reduces the chemoresistance of melanoma by inhibiting the TYMS/PLK1 signaling axis

CELL DEATH & DISEASE

IF9.6

2024-10-010

OAAI

Corrigendum: Association between meeting 24-h movement guidelines and health in children and adolescents aged 5-17 years: a systematic review and meta-analysis

FRONTIERS IN PUBLIC HEALTH

IF3.4

2024-07-190

OAAI

Association of dietary selenium intake and all-cause mortality of Parkinson's disease and its interaction with blood cadmium level: a retrospective cohort study

IF3.8

2024-05-103

OAAI

Association between meeting 24-h movement guidelines and health in children and adolescents aged 5-17 years: a systematic review and meta-analysis

FRONTIERS IN PUBLIC HEALTH

IF3.4

2024-05-079

OAAI

Effects of Ganjianglingzhu Decoction on Lean Non-Alcoholic Fatty Liver Disease in Mice Based on Untargeted Metabolomics

PHARMACEUTICALS

IF4.8

2024-04-155

OAAI

Progress and hotspot of diet or exercise therapy in the treatment of non-alcoholic fatty liver disease

饮食或运动疗法治疗非酒精性脂肪性肝病的研究进展及热点

FRONTIERS IN NUTRITION

IF5.1

2024-04-023

OAAI

DNA methylation of SMPD3-based diagnostic biomarkers of NASH and mild fibrosis

NASH和轻度纤维化的SMPD3-based诊断生物标志物的DNA甲基化

GENES & DISEASES

IF9.4

2024-01-011

OAAI

Progression of radiographic fibrosis in rheumatoid arthritis-associated interstitial lung disease

FRONTIERS IN MEDICINE

IF3

2023-09-229

OAAI

Waist circumference mediates the association between rs1260326 in GCKR gene and the odds of lean NAFLD

SCIENTIFIC REPORTS

IF3.9

2023-04-205

OAAI

Claudin and pancreatic cancer

FRONTIERS IN ONCOLOGY

IF3.3

2023-03-0721

OAAI

The Adsorption of CTC onto CFBs: A Study on Fabrication of Magnetic Cellulose/Fe3O4 Beads (CFBs) and Adsorption Kinetics

IF3.2

2023-01-302

OAAI

Establishment of quantitative nested-PCR of Abelson interactor 1 transcript variant-11

IF3.6

2022-12-010

OAAI

The gender-specific bidirectional relations between chronic diseases and total bilirubin/urea in the elderly population: A 3-year longitudinal study

FRONTIERS IN PUBLIC HEALTH

IF3.4

2022-11-095

OAAI

Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation

CELL AND BIOSCIENCE

IF6.2

2021-11-048

OAAI

Towards early risk biomarkers: serum metabolic signature in childhood predicts cardio-metabolic risk in adulthood

早期风险生物标志物: 儿童血清代谢特征预测成年期心脏代谢风险

IF10.8

2021-10-0118

OAAI